Talk:Saxagliptin

Efficacy
Agree the efficacy is not impressive, but disagree lack of of impact on CV outcomes merits 2 of the first 5 sentences the article, as competing therapies have zero ornegative CV impact. Lack of weight gain is one of the attractive features of this class and part of why class is so popular, but does not get early mention.Formerly 98 (talk) 17:15, 7 March 2014 (UTC)

External links modified
Hello fellow Wikipedians,

I have just added archive links to 1 one external link on Saxagliptin. Please take a moment to review my edit. If necessary, add after the link to keep me from modifying it. Alternatively, you can add to keep me off the page altogether. I made the following changes:
 * Added archive https://web.archive.org/20070930160341/http://www.delawareonline.com/apps/pbcs.dll/article?AID=/20070111/BUSINESS/70111024/-1/NLETTER02 to http://www.delawareonline.com/apps/pbcs.dll/article?AID=/20070111/BUSINESS/70111024/-1/NLETTER02

When you have finished reviewing my changes, please set the checked parameter below to true to let others know.

Cheers.—cyberbot II  Talk to my owner :Online 12:27, 19 February 2016 (UTC)

Source Quality
I saw that one of the references included in the article comes from a lawsuit-oriented websited called DrugNews (citation number 11). Since I have a COI with all kind of lawsuits against drug topics, I can't edit it manually, but as far as I know, this kind of reference is against Wiki rules. I suggest either to remove that short sentence altogether, since it does not add any interesting information from an encyclopedic point of view, or to substitute it with another source (I found an article on Medscape "FDA Panel Backs New Safety Warnings on Two Diabetes Drugs" by Alicia Ault) which has a more neutral point of view. Can I do the modifications User:Doc_James ? Daimyo2 (talk) 12:09, 14 June 2016 (UTC)Daimyo2